… The absence of randomized data in both the developed and developing world has required
antiretroviral treatment guidelines to rely on the interpretation of nonrandomized studies and …

… ARV treatment share. By 2007, only two unique regimens were used in the treatment of over
95% of patients starting ARV … in this patient population could be considered. Successfully …

… persons might reflect mutations that were once linked in oligoclonal populations and … naïve
populations, we then assessed the impact of low-frequency resistance mutations on treatment …

… The population in this study had more advanced HIV disease and had a larger proportion of
… CDC study and is surprisingly high for a population with advanced disease. Both exceed the …

… in an HIV-infected population enrolled more recently [ 8 , 9 ], which suggests that minor
drug-resistant variants are still a factor in antiretroviral therapy–naive populations. Further, in our …

… treatment programmes. We aimed to estimate changes in the prevalence of HIV-1 drug
resistance in treatment-naive … Despite intending to select studies of drug-naive populations, our …

… Population groups experiencing lower incidence of adherence in this study among
treatment-naive patients are consistent with that among treatment-experienced HIV-infected patients. …

… population of drug-naive … ARV drug-naive HIV-infected mother whose serologic status was
unknown during pregnancy and even after the child's birth; therefore, the child was not treated …

… antiretroviral treatment has … antiretroviral treatment in northern South Africa. In the intervening
time, there is a possibility of resistance emergence and transmission to naïve populations …

… Antiretroviral treatment guidelines may also indirectly … The population examined in this
study was of particular interest, because it was geographically diverse and included ART-naïve …